Literature DB >> 8475556

Risk factors for primary dysfunction after liver transplantation--a multivariate analysis.

R J Ploeg1, A M D'Alessandro, S J Knechtle, M D Stegall, J D Pirsch, R M Hoffmann, T Sasaki, H W Sollinger, F O Belzer, M Kalayoglu.   

Abstract

In a retrospective analysis on 323 orthotopic liver transplant procedures performed between July 1984 and October 1991 the incidence of two forms of primary dysfunction (PDF) of the liver: primary nonfunction (PNF), and initial poor function (IPF) were studied. The incidence of PDF was 22% (73/323) with 6% PNF (20/323) and 16% IPF (53/323), while 78% (250/323) had immediate function (IF). Occurrence of both IPF and PNF resulted in a higher graft failure rate (P < 0.001), retransplantation rate (P < 0.001), and patient mortality (P < 0.003) within the first three months after OLTx. Univariate analyses of donor and recipient factors and their influence on PDF demonstrated that longer donor hospitalization (> 3 days), older donor age (> 49 years), extended preservation times (> 18 hr), and fatty changes in the donor liver biopsy, as well as reduced-size livers, younger recipient age, and renal insufficiency prior to OLTx, significantly affected the incidence of IPF and PNF. Multivariate analysis of potential risk factors showed that reduced-size liver (P = 0.0001), fatty changes on donor liver biopsy (P = 0.001), older donor age (P = 0.009), retransplantation (P = 0.01), renal insufficiency (P = 0.02), and prolonged cold ischemia times (P = 0.02) were independently associated with a higher incidence of IPF and PNF. No statistical correlation was found between PDF and etiology of ESLD, nutritional status of the recipient, UNOS status, and Child-Pugh classification in this study. We conclude that PNF and IPF are both separate clinical entities that have a significant effect on outcome after OLTx. Routine donor liver biopsies are recommended to decrease the rate of IPF and PNF. The combination of risk factors shown to be significant for PDF should be avoided--and, if that is not possible, the only variable that can be controlled, the preservation time, should be kept as short as possible.

Entities:  

Mesh:

Year:  1993        PMID: 8475556     DOI: 10.1097/00007890-199304000-00024

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  134 in total

1.  Prevention of grafted liver from reperfusive injury.

Authors:  K Ma; Y Yu; X M Bu; Y J Li; X W Dai; L Wang; Y Dai; H Y Zhao; X H Yang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 2.  Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy.

Authors:  Scott B Reeder; Irene Cruite; Gavin Hamilton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2011-09-16       Impact factor: 4.813

3.  Simultaneous assessment of liver volume and whole liver fat content: a step towards one-stop shop preoperative MRI protocol.

Authors:  Gaspard d'Assignies; Claude Kauffmann; Yvan Boulanger; Marc Bilodeau; Valérie Vilgrain; Gilles Soulez; An Tang
Journal:  Eur Radiol       Date:  2010-09-03       Impact factor: 5.315

Review 4.  Quantification of liver fat with magnetic resonance imaging.

Authors:  Scott B Reeder; Claude B Sirlin
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-08       Impact factor: 2.266

5.  Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost.

Authors:  Patrick G Northup; Michael M Abecassis; Michael J Englesbe; Jean C Emond; Vanessa D Lee; George J Stukenborg; Lan Tong; Carl L Berg
Journal:  Liver Transpl       Date:  2009-02       Impact factor: 5.799

6.  TIM-1 attenuates the protection of ischemic preconditioning for ischemia reperfusion injury in liver transplantation.

Authors:  Yu Zhang; Yuanxing Liu; Hui Chen; Xiaoxiao Zheng; Shangzhi Xie; Wei Chen; Haofeng Ji; Shusen Zheng
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

7.  The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury.

Authors:  Kim H H Liss; Kyle S McCommis; Kari T Chambers; Terri A Pietka; George G Schweitzer; Sara L Park; Ilke Nalbantoglu; Carla J Weinheimer; Angela M Hall; Brian N Finck
Journal:  Liver Transpl       Date:  2018-07       Impact factor: 5.799

8.  Ischemic preconditioning decreases C-X-C chemokine expression and neutrophil accumulation early after liver transplantation in rats.

Authors:  Yong Jiang; Xiao-Ping Gu; Yu-Dong Qiu; Xue-Mei Sun; Lei-Lei Chen; Li-Hua Zhang; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

9.  Induction of ischemic tolerance in rat liver via reduced nicotinamide adenine dinucleotide phosphate oxidase in Kupffer cells.

Authors:  Kazuaki Tejima; Masahiro Arai; Hitoshi Ikeda; Tomoaki Tomiya; Mikio Yanase; Yukiko Inoue; Takako Nishikawa; Naoko Watanabe; Natsuko Ohtomo; Masao Omata; Kenji Fujiwara
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

Review 10.  Managing nonalcoholic fatty liver disease: recommendations for family physicians.

Authors:  Ignazio Grattagliano; Piero Portincasa; Vincenzo O Palmieri; Giuseppe Palasciano
Journal:  Can Fam Physician       Date:  2007-05       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.